Skip to main content
Journal cover image

Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study

Publication ,  Conference
Charlton, MR; O'Leary, JG; Bzowej, NH; Muir, AJ; Korenblat, KM; Fenkel, JM; Reddy, KR; Lawitz, E; Schiano, TD; Teperman, LW; Fontana, RJ ...
Published in: HEPATOLOGY
December 1, 2015

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

December 1, 2015

Volume

62

Issue

6

Start / End Page

1387A / 1388A

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Charlton, M. R., O’Leary, J. G., Bzowej, N. H., Muir, A. J., Korenblat, K. M., Fenkel, J. M., … Curry, M. P. (2015). Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. In HEPATOLOGY (Vol. 62, pp. 1387A-1388A). WILEY-BLACKWELL.
Charlton, Michael R., Jacqueline G. O’Leary, Natalie H. Bzowej, Andrew J. Muir, Kevin M. Korenblat, Jonathan M. Fenkel, K Rajender Reddy, et al. “Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study.” In HEPATOLOGY, 62:1387A-1388A. WILEY-BLACKWELL, 2015.
Charlton MR, O’Leary JG, Bzowej NH, Muir AJ, Korenblat KM, Fenkel JM, et al. Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 1387A-1388A.
Charlton, Michael R., et al. “Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study.” HEPATOLOGY, vol. 62, no. 6, WILEY-BLACKWELL, 2015, pp. 1387A-1388A.
Charlton MR, O’Leary JG, Bzowej NH, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Schiano TD, Teperman LW, Fontana RJ, Schiff ER, Fried MW, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Curry MP. Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 1387A-1388A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

December 1, 2015

Volume

62

Issue

6

Start / End Page

1387A / 1388A

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics